← Back to catalogue

Alinity

FDA UDI

Class II (US FDA UDI)

by Abbott

Identity

Trade Name
Alinity FDA UDI
Generic Name
Cancer antigen 125 (CA125) IVD, kit, chemiluminescent immunoassay FDA UDI
Device Name
Alinity i ROMA FDA UDI
Model / Reference
03R7521 FDA UDI
Description
Alinity i ROMA FDA UDI

Identifiers

Catalog Number
03R7521 FDA UDI
Primary DI / UDI-DI
00380740146269 FDA UDI
FDA Product Code
ONX FDA UDI
GMDN Term
Cancer antigen 125 (CA125) IVD, kit, chemiluminescent immunoassay FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.6050 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cancer antigen 125 (CA125) IVD, kit, chemiluminescent immunoassayHuman epididymis protein 4 (HE4) IVD, kit, chemiluminescent immunoassay

Alinity by Abbott — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Human epididymis protein 4 (HE4) IVD, kit, chemiluminescent immunoassay.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Abbott

Sources (1)

  • FDA UDI 0768e505-dfff-489e-8680-2c7a41d938c7 35 fields · synced May 31, 2026